FLT3-ITD-mutated AML is most frequently characterized by normal karyotype, myeloblastic/monoblastic differentiation, poor prognosis with a high leukemic burden at diagnosis, and shorter OS, if compared with FLT3-ITD-unmutated patients, due to its strong relapse tendency [12,13]. This evidence concerns the gene FLT3 and acute myeloid leukemia.